发明申请
US20100048641A1 Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases
审中-公开
使用腺苷A1和/或双重A1 / 2ab激动剂生产用于治疗疾病的药物
- 专利标题： Use of Adenosine A1 and/or Dual A1/2ab Agonists for Production of Medicaments for Treating Diseases
- 专利标题（中）： 使用腺苷A1和/或双重A1 / 2ab激动剂生产用于治疗疾病的药物
-
申请号： US12224417申请日： 2007-02-16
-
公开(公告)号： US20100048641A1公开(公告)日： 2010-02-25
- 发明人: Peter Nell , Barbara Albrecht-Küpper , Walter Hübsch , Martina Wuttke , Thomas Krahn , Nicole Diedrichs , Hilmar Bischoff
- 申请人： Peter Nell , Barbara Albrecht-Küpper , Walter Hübsch , Martina Wuttke , Thomas Krahn , Nicole Diedrichs , Hilmar Bischoff
- 申请人地址： DE LEVERKUSEN
- 专利权人： BAYER HEALTHCARE AG LAW AND PATENTS,PATENTS AND LICENSING
- 当前专利权人： BAYER HEALTHCARE AG LAW AND PATENTS,PATENTS AND LICENSING
- 当前专利权人地址： DE LEVERKUSEN
- 优先权： DE102006009813,7 20060301
- 国际申请： PCT/EP2007/001342 WO 20070216
- 主分类号： A61K31/4439
- IPC分类号： A61K31/4439 ; C07D417/12 ; A61P3/00 ; A61P3/10
摘要：
The present invention relates to the use of A1 and/or dual A1/A2b agonists of the formulae (IA) and (IB) for preparing a medicament for treating dyslipidemia, metabolic syndrome and diabetes and dyslipidemia, metabolic syndrome and diabetes in association with hypertension and cardiovascular disorders.